Abstract

Diverticulitis has a tendency to recur and affect quality of life. To assess whether sigmoid resection is superior to conservative treatment in improving quality of life of patients with recurrent, complicated, or persistent painful diverticulitis. This open-label randomized clinical trial assessed for eligibility 128 patients with recurrent, complicated, or persistent painful diverticulitis in 6 Finnish hospitals from September 29, 2014, to October 10, 2018. Exclusion criteria included age younger than 18 years or older than 75 years; lack of (virtual) colonoscopy or sigmoidoscopy data within 2 years, or presence of cancer, contraindication to laparoscopy, or fistula. Outcomes were assessed using intention-to-treat analysis. A prespecified interim analysis was undertaken when 66 patients had been randomized and their 6-month follow-up was assessable. Data were analyzed from June 2018 to May 2020. Laparoscopic sigmoid resection or conservative treatment. The primary outcome was difference in Gastrointestinal Quality of Life Index (GIQLI) score between randomization and 6 months. Of 128 patients assessed for eligibility, 90 were randomized (28 male [31%]; mean [SD] age, 54.11 [11.9] years; 62 female [69%]; mean [SD] age, 57.13 [7.6] years). A total of 72 patients were included in analyses for the primary outcome (37 in the surgery group and 35 in the conservative treatment group), and 85 were included in analyses for clinical outcomes (41 in the surgery group and 44 in the conservative treatment group). The difference between GIQLI score at randomization and 6 months was a mean of 11.96 points higher in the surgery group than in the conservative treatment group (mean [SD] of 11.76 [15.89] points vs -0.2 [19.07] points; difference, 11.96; 95% CI, 3.72-20.19; P = .005). Four patients (10%) in the surgery group and no patients in the conservative treatment group experienced major complications (Clavien-Dindo grade III or higher). There were 2 patients (5%) in the surgery group and 12 patients (31%) in the conservative treatment group who had new episodes of diverticulitis within 6 months. In this randomized clinical trial, elective laparoscopic sigmoid resection improved quality of life in patients with recurrent, complicated, or persistent painful diverticulitis but carried a 10% risk of major complications. ClinicalTrials.gov Identifier: NCT02174926.

Highlights

  • Even a single recurrence in young patients or a second recurrence in elderly patients often led to elective sigmoid resection to prevent recurrence.[7]

  • Recurrent diverticulitis reduces patients’ quality of life (QOL), whereas QOL could be improved by elective sigmoid resection.[14,15,16]

  • Because of the 6-month follow-up time required for the assessment of the results of these 66 patients, an additional 24 patients had already been recruited during this lag period, and they were included in the final analyses

Read more

Summary

Methods

Study Design The LASER trial was a multicenter, prospective, parallel, openlabel randomized clinical trial comparing elective laparoscopic sigmoid resection with conservative treatment in patients with either recurrent, complicated, or persistent painful diverticulitis. The trial was carried out in 2 academic university hospitals (Helsinki and Oulu university hospitals) and 3 community hospitals (Seinäjoki Central, Vaasa Central, and Hyvinkää hospitals) in Finland. This study followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline. The trial protocol was approved by the ethical committee of the Helsinki University Hospital and institutional review boards at each site and can be found in Supplement 1. The trial was registered in ClinicalTrials.gov before commencement. A new study site (Hyvinkää Central Hospital) was added to the protocol, but no other changes were

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call